NBRV - Nabriva Therapeutics EPS misses by $0.15 beats on revenue
- Nabriva Therapeutics (NASDAQ:NBRV): Q2 GAAP EPS of -$0.30 misses by $0.15.
- More news on: Nabriva Therapeutics plc, Earnings news and commentary, Healthcare stocks news, , Read more ...
Link your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Stock Information
| Company Name: | Nabriva Therapeutics plc |
| Stock Symbol: | NBRV |
| Market: | NASDAQ |
Get NBRV Alerts
News, Short Squeeze, Breakout and More Instantly...